Alzheimer&Amp;#39;s Disease Clinical Trials

6 recruitingLast updated: June 17, 2026

There are 6 actively recruiting alzheimer's disease clinical trials across 3 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Houston, Texas, United States, Los Angeles, California, United States, Pozzilli, Italy, Italy. Updated daily from ClinicalTrials.gov.


Alzheimer&Amp;#39;s Disease Trials at a Glance

6 actively recruiting trials for alzheimer's disease are listed on ClinicalTrialsFinder across 5 cities in 3 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Houston, Los Angeles, and Pozzilli. Lead sponsors running alzheimer's disease studies include Baylor College of Medicine, Chang Gung Memorial Hospital, and Neuromed IRCCS.

Browse alzheimer's disease trials by phase

Treatments under study

About Alzheimer&Amp;#39;s Disease Clinical Trials

Looking for clinical trials for Alzheimer&Amp;#39;s Disease? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Alzheimer&Amp;#39;s Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Alzheimer&Amp;#39;s Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 16 of 6 trials

Recruiting
Not Applicable

Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease

Alzheimer DiseaseAlzheimer&Amp;#39;s Disease-related DementiarTMS Stimulation
Baylor College of Medicine20 enrolled1 locationNCT06835283
Recruiting

Phosphorylated Tau Levels in Donated Blood

Alzheimer&Amp;#39;s Disease
The University of Texas Health Science Center, Houston250 enrolled1 locationNCT07157839
Recruiting
Phase 1Phase 2

Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)

Alzheimer DiseaseAlzheimer&Amp;Amp;#39;s DiseaseDementia Alzheimer Type+4 more
University of California, Los Angeles54 enrolled1 locationNCT06597942
Recruiting
Not Applicable

Remote tDCS and Chair Yoga for Chronic Knee Pain in Alzheimer's Patients

Alzheimer&Amp;#39;s DiseaseOther Dementias
University of Arizona40 enrolled1 locationNCT07303998
Recruiting

Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders

Parkinson DiseaseAmyotrophic Lateral Sclerosis(ALS)Alzheimer&Amp;#39;s Disease (AD)+1 more
Neuromed IRCCS110 enrolled1 locationNCT06803784
Recruiting
Not Applicable

Effects of Endogenous Gamma Light Stimulation on Brain Oscillations in Cognitively-normal Older Adults

EEG Brain OscillationsAlzheimer&Amp;#39;s Disease (AD)Cognitively Normal Older Adults
Chang Gung Memorial Hospital52 enrolled1 locationNCT06715995